Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Piramal Pharma Completes Kenalog Product Acquisition
Closed
HealthcareDivestiture
Deal Overview
Piramal Pharma has completed the acquisition of the Kenalog injectable product from Bristol-Myers Squibb. The transaction is described as a divestiture and is marked closed.
The excerpt provides no additional deal economics, product scope details, or closing timing beyond completion.
Key Details
- Transaction
- Piramal Pharma acquires Kenalog Injectable Product
Related Deals
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. for €7.5m to Expand EU Reach - scanx.trade
HealthcareAdd-on
Marksans Pharma→QliniQ
Jun 1, 2026
Altruix Acquired By Frazier Healthcare Partners And Randy Hyun Appointed CEO - Pulse 2.0
HealthcareOther
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
HealthcareOther
Signos
May 31, 2026
Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
HealthcareCaliforniaOther
Sterling Bay→Pacific Center
May 29, 2026